Literature DB >> 15725935

Urolithiasis and obesity: metabolic and technical considerations.

Robert C Calvert1, Neil A Burgess.   

Abstract

PURPOSE OF REVIEW: The increasing prevalence of obesity poses a challenge to urologists in the diagnosis and treatment of urolithiasis. This review summarizes the new evidence linking obesity and urolithiasis, and the technical considerations and modifications necessary in the diagnosis and treatment of stone disease in obese patients. RECENT
FINDINGS: Recent studies have confirmed the epidemiological link between obesity and urolithiasis, and have provided some possible explanations for its underlying cause. New clinical series have demonstrated that flexible ureterorenoscopy and adapted percutaneous nephrolithotomy techniques can result in similar stone clearance rates and morbidity to the non-obese patient. New data, however, suggest that obesity may be an independent predictor of extracorporeal shock wave lithotripsy treatment failure for ureteric stones. Evidence of the efficacy of dietary modification and medical treatment of metabolic abnormalities has been reported in obese stone formers.
SUMMARY: Urolithiasis can be safely and effectively managed in obese patients with minor modifications to the established surgical techniques. Increased understanding of the underlying metabolic abnormalities in obese patients with urolithiasis may improve prevention strategies in the future.

Entities:  

Mesh:

Year:  2005        PMID: 15725935     DOI: 10.1097/01.mou.0000160626.36236.22

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  18 in total

1.  Effectiveness of retrograde intrarenal stone surgery in obese patients.

Authors:  O G Doluoglu; T Karakan; M Kabar; B C Ozgur; A M Hascicek; E Huri; B Resorlu
Journal:  Ir J Med Sci       Date:  2015-11-11       Impact factor: 1.568

Review 2.  Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms.

Authors:  Ozgu Aydogdu
Journal:  World J Nephrol       Date:  2012-02-06

3.  [Effect of the body mass index on outcomes of ureterorenoscopy for renal stones].

Authors:  F Schott; S Knipper; A K Orywal; A J Gross; C Netsch
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

Review 4.  Ureteroscopy and stones: Current status and future expectations.

Authors:  Anna E Wright; Nicholas J Rukin; Bhaskar K Somani
Journal:  World J Nephrol       Date:  2014-11-06

Review 5.  Sky is no limit for ureteroscopy: extending the indications and special circumstances.

Authors:  Guido Giusti; Silvia Proietti; Roberto Peschechera; Gianluigi Taverna; Giuseppe Sortino; Luca Cindolo; Pierpaolo Graziotti
Journal:  World J Urol       Date:  2014-06-25       Impact factor: 4.226

6.  Comparison of STONE, CROES and Guy's nephrolithometry scoring systems for predicting stone-free status and complication rates after percutaneous nephrolithotomy in obese patients.

Authors:  Faruk Ozgor; Fatih Yanaral; Metin Savun; Harun Ozdemir; Omer Sarilar; Murat Binbay
Journal:  Urolithiasis       Date:  2017-07-29       Impact factor: 3.436

7.  The effect of abdominal fat parameters on percutaneous nephrolithotomy success.

Authors:  Ozgur Cakmak; Huseyin Tarhan; Sertac Cimen; Rahmi Gokhan Ekin; Ilker Akarken; Ozgur Oztekin; Ertan Can; Tufan Suelozgen; Yusuf Ozlem Ilbey
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

Review 8.  History, epidemiology and regional diversities of urolithiasis.

Authors:  Michelle López; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

9.  Effect of the body mass index on outcomes of flexible ureterorenoscopy.

Authors:  Erhan Sari; Abdulkadir Tepeler; Emrah Yuruk; Berkan Resorlu; Tolga Akman; Murat Binbay; Abdullah Armagan; Ali Unsal; Ahmet Yaser Muslumanoglu
Journal:  Urolithiasis       Date:  2013-07-23       Impact factor: 3.436

10.  Body mass index, body fat percentage, and the effect of body fat mass on SWL success.

Authors:  Ali Ferruh Akay; Abdullah Gedik; Ali Tutus; Hayrettin Sahin; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2007-03-16       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.